# FDA Inspection 1232759 - Vanda Pharmaceuticals Inc - March 12, 2024

Source: https://www.keypedia.com/records/fda_inspections/vanda-pharmaceuticals-inc/718fbba5-962f-4f9f-94d3-5529997f55a7
Source feed: FDA_Inspections

> FDA Inspection 1232759 for Vanda Pharmaceuticals Inc on March 12, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1232759
- Company Name: Vanda Pharmaceuticals Inc
- Inspection Date: 2024-03-12
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1103014 - 2019-09-09](https://www.keypedia.com/records/fda_inspections/vanda-pharmaceuticals-inc/b7729109-1ab9-4158-b35b-d1fca47fa373)

Company: https://www.keypedia.com/companies/vanda-pharmaceuticals-inc/a60e506d-9654-41ce-a906-98706debec71

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c